Result? Today we have a problem related to under-treatment: according to research carried out in 2020, just before the Covid-19 pandemic exploded, about 30% of patients eligible for therapy with biological or biosimilar drugs were without treatment. This is due to the imposition by some Regions, especially in those where there is a greater penetration of the biosimilar drug, which alarmed the doctor who feared losing prescribing freedom β. βThe patient who did not know biosimilar drugs β continues Celano β thought that they were not safe drugs. ![]() I repeat, there was a lack of correct information, particularly when patients saw themselves changing the drug, with the transition from biologic to biosimilar. ![]() Everything passes through communication and everything passes through the trust you have in your doctor.
0 Comments
Leave a Reply. |